Table 3. Discounted life expectancy, in... | American Society of Hematology

Table 3.

Discounted life expectancy, in years, for alternative transplantation strategies

	Transplantation at diagnosis	Transplantation at a fixed time point							Transplantation at AML progression
Patients, by IPSS risk group	Transplantation at diagnosis		2y	4y	6y	8y			Transplantation at AML progression
All patients
Low	6.51	6.86	7.47	7.46	7.49^*	7.21
Int-1	4.61	4.74	4.72	5.02	5.20^*	5.16
Int-2	4.93^*	3.21	2.94	2.85	2.84	2.84
High	3.20^*	2.75	2.75	2.75	2.75	2.75
Patients younger than 40 y
Low	5.62	6.63	7.53	8.32	9.00	10.21^*
Int-1	2.48	4.04	5.37	6.53	7.49	10.21^*
Int-2	1.65^*	1.48	1.51	1.52	1.53	1.53
High	—	—	—	—	—	—

	Transplantation at diagnosis	Transplantation at a fixed time point							Transplantation at AML progression
Patients, by IPSS risk group	Transplantation at diagnosis		2y	4y	6y	8y			Transplantation at AML progression
All patients
Low	6.51	6.86	7.47	7.46	7.49^*	7.21
Int-1	4.61	4.74	4.72	5.02	5.20^*	5.16
Int-2	4.93^*	3.21	2.94	2.85	2.84	2.84
High	3.20^*	2.75	2.75	2.75	2.75	2.75
Patients younger than 40 y
Low	5.62	6.63	7.53	8.32	9.00	10.21^*
Int-1	2.48	4.04	5.37	6.53	7.49	10.21^*
Int-2	1.65^*	1.48	1.51	1.52	1.53	1.53
High	—	—	—	—	—	—

—indicates in sufficient data to perform analysis.

Dominant strategies.